Controversies and Treatment Decisions in Staph Aureus Bacteremia Management

The chapter delves into controversies surrounding Staph aureus bacteremia evaluation and management, covering topics like ID consultation, molecular testing benefits, imaging role, antibiotic dosing, and treatment duration. It explores various treatment decisions for MSSA and MRSA, including the use of vancomycin, daptomycin, cephalosporins, and combination therapies. The chapter also addresses challenges like persistently positive cultures, antibiotic toxicity, and patient scenarios complicating treatment, such as substance use disorders.